CERYVYN THRAPEUTICS (OPTEY) Net Income by Year
CERYVYN THRAPEUTICS reported a net loss of $162.8M in fiscal year 2025. This represents an increase of 26.1% from the prior fiscal year. The table below carries 7 fiscal years, from 2019 to 2025, and the quarters CERYVYN THRAPEUTICS has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
OPTEY Net Income by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
OPTEY Net Income by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What net income means
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.
More CERYVYN THRAPEUTICS financials
Frequently Asked Questions
What was CERYVYN THRAPEUTICS's net income in fiscal year 2025?
CERYVYN THRAPEUTICS reported a net loss of $162.8M in fiscal year 2025.
How fast is CERYVYN THRAPEUTICS's net income growing?
CERYVYN THRAPEUTICS (OPTEY) net income rose by 26.1% year over year, from -$220.2M to -$162.8M in fiscal year 2025.
How has CERYVYN THRAPEUTICS's net income changed over the years?
Across the 7 fiscal years this page covers, CERYVYN THRAPEUTICS (OPTEY) net income went from -$15.0M in fiscal year 2019 to -$162.8M in fiscal year 2025.
What does net income mean on a financial statement?
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what CERYVYN THRAPEUTICS (OPTEY) reported on that line in every period on record.